MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jceh.2020.09.005

Медицинская библиотека · Journal of clinical and experimental hepatology · 2020

INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease.

Arora Anil, Kumar Ashish, Prasad Narayan, Duseja Ajay, Acharya Subrat K, Agarwal Sanjay K, Aggarwal Rakesh, Anand Anil C, Bhalla Anil K, Choudhary Narendra S, Chawla Yogesh K, Dhiman Radha K, Dixit Vinod K, Gopalakrishnan Natarajan, Gupta Ashwani, Hegde Umapati N, Jasuja Sanjiv, Jha Vivek, Kher Vijay, Kumar Ajay, Madan Kaushal, Maiwall Rakhi, Mathur Rajendra P, Nayak Suman L, Pandey Gaurav, Pandey Rajendra, Puri Pankaj, Rai Ramesh R, Raju Sree B, Rana Devinder S, Rao Padaki N, Rathi Manish, Saraswat Vivek A, Saxena Sanjiv, Shalimar, Sharma Praveen, Singh Shivaram P, Singal Ashwani K, Soin Arvinder S, Taneja Sunil, Varughese Santosh

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Renal dysfunction is very common among patients with chronic liver disease, and concomitant liver disease can occur among patients with chronic kidney disease. The spectrum of clinical presentation and underlying etiology is wide when concomitant kidney and liver disease occur in the same patient. Management of these patients with dual onslaught is challenging and requires a team approach of hepatologists and nephrologists. No recent guidelines exist on algorithmic approach toward diagnosis and management of these challenging patients. The Indian National Association for Study of Liver (INASL) in association with Indian Society of Nephrology (ISN) endeavored to develop joint guidelines on diagnosis and management of patients who have simultaneous liver and kidney disease. For generating these guidelines, an INASL-ISN Taskforce was constituted, which had members from both the societies. The taskforce first identified contentious issues on various aspects of simultaneous liver and kidney diseases, which were allotted to individual members of the taskforce who reviewed them in detail. A round-table meeting of the Taskforce was held on 20-21 October 2018 at New Delhi to discuss, debate, and finalize the consensus statements. The evidence and recommendations in these guidelines have been graded according to the Grading of Recommendations Assessment Development and Evaluation (GRADE) system with minor modifications. The strength of recommendations (strong and weak) thus reflects the quality (grade) of underlying evidence (I, II, III). We present here the INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease.

Для цитирования: Arora Anil, Kumar Ashish, Prasad Narayan, Duseja Ajay, Acharya Subrat K, Agarwal Sanjay K, Aggarwal Rakesh, Anand Anil C, Bhalla Anil K, Choudhary Narendra S, Chawla Yogesh K, Dhiman Radha K, Dixit Vinod K, Gopalakrishnan Natarajan, Gupta Ashwani, Hegde Umapati N, Jasuja Sanjiv, Jha Vivek, Kher Vijay, Kumar Ajay, Madan Kaushal, Maiwall Rakhi, Mathur Rajendra P, Nayak Suman L, Pandey Gaurav, Pandey Rajendra, Puri Pankaj, Rai Ramesh R, Raju Sree B, Rana Devinder S, Rao Padaki N, Rathi Manish, Saraswat Vivek A, Saxena Sanjiv, Shalimar, Sharma Praveen, Singh Shivaram P, Singal Ashwani K, Soin Arvinder S, Taneja Sunil, Varughese Santosh. INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease.. Journal of clinical and experimental hepatology. 2020. DOI: 10.1016/j.jceh.2020.09.005.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.